Lluisa Miro
Barcelona, CT 08028, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 06, 2025
Soluble Epoxide Hydrolase Inhibition Improves Alzheimer's Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation.
Journal: Aging and disease
Published: February 14, 2025
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition.
Journal: Frontiers in pharmacology
Published: December 18, 2024
Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 22, 2024
Infection of mice by the enteroaggregative E. coli strain 042 and two mutant derivatives overexpressing virulence factors: impact on disease markers, gut microbiota and concentration of SCFAs in feces.
Journal: Scientific reports
Published: April 16, 2024
Dietary intake of table olives exerts antihypertensive effects in association with changes in gut microbiota in spontaneously hypertensive rats.
Journal: Food & function
Published: March 02, 2023
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer's Disease.
Journal: Aging and disease
Published: January 22, 2023
Dietary supplementation with spray-dried animal plasma improves vaccine protection in aged mice.
Journal: Frontiers in nutrition
Published: September 22, 2022
Reply to Nifli, A.-P. Comment on "Rosell-Cardona et al. Dietary Spray-Dried Porcine Plasma Reduces Neuropathological Alzheimer's Disease Hallmarks in SAMP8 Mice. Nutrients 2021, 13, 2369".
Journal: Nutrients
Published: September 30, 2021
Last Updated: 09/26/2026